,Year,Title,Altmetric
0,2020,"Erratum: Mesenchymal Niche-Specific Expression of Cxcl12 Controls Quiescence of Treatment-Resistant Leukemia Stem Cells (Cell Stem Cell (2019) 24(5) (769â€“784.e6), (S1934590919300700), (10.1016/j.stem.2019.02.018)). Cell Stem Cell. 26:123.  2020  10.1016/j.stem.2019.11.013",
1,2019,Mesenchymal Niche-Specific Expression of Cxcl12 Controls Quiescence of Treatment-Resistant Leukemia Stem Cells. Cell Stem Cell. 24:769-784.e6.  2019  10.1016/j.stem.2019.02.018,
2,2019,SIRT1 regulates metabolism and leukemogenic potential in CML stem cells. Journal of Clinical Investigation. 129:2685-2701.  2019  10.1172/JCI127080,
3,2017,Clonal hematopoiesis associated with adverse outcomes after autologous stem-cell transplantation for lymphoma. Journal of Clinical Oncology. 35:1598-1605.  2017  10.1200/JCO.2016.71.6712,
4,2016,A microscopic landscape of the invasive breast cancer genome. Scientific Reports. 6.  2016  10.1038/srep27545,
5,2016,ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast. Oncotarget. 7:80655-80663.  2016  10.18632/oncotarget.13019,
6,2016,Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma. Oncotarget. 7:1598-1607.  2016  10.18632/oncotarget.6408,
